Laxmi Kant Sharma
Research Subjects
Laxmi Kant Sharma has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
- Anurag Yadav
Department of Urology, Pushpanjali Hospital and Research Centre, Agra, India
2 shared publications - Dilip Kumar Mishra
Department of Urology, Pushpanjali Hospital and Research Centre, Agra, Uttar Pradesh, India
2 shared publications - Gaurav Sharma
Department of Urology, Pushpanjali Hospital and Research Centre, Agra, India
2 shared publications - Madhu Sudan Agrawal
Institute of Urology and Renal Sciences, Pushpanjali Hospital and Research Centre, Agra, India
2 shared publications - Naveen Kumar
Department of Urology, Pushpanjali Hospital and Research Centre, Agra, India
2 shared publications - Diptiranjan Bai
Department of Urology, Pushpanjali Hospital and Research Centre, Agra, India
1 shared publication
Latest Publications
- 30 June 2025
- Published by Springer Nature in Urolithiasis
- Vol. 53 (1) , 1-9
Does suction in Mini PCNL mitigate rise in intrarenal pressure? A prospective randomised study
The rise in intra-renal pressure during Mini PCNL (percutaneous nephrolithotripsy) potentially leads to pyelovenous backflow and infectious complications. This prospective randomized study compares intra-renal pressure (IRP) in patients undergoing Mini PCNL (mPCNL) procedure with and without suction for renal stones. Suction mPCNL is expected to lower IRP by continuously aspirating irrigation fluid and stone fragments, thereby enhancing procedural safety. A total of 100 patients with kidney stones measuring 1–4 cm were randomized into two groups: Mini PCNL with suction (n = 50) and Mini PCNL without suction (n = 50). IRP was measured using a pressure transducer connected to a ureteral catheter. Key outcome measures included intra-renal pressure, stone-free rate, operative time, and complication rates. The suction mPCNL group demonstrated a significantly lower IRP (16.92 ± 2.93 mmHg) compared to the non-suction group (19.48 ± 4.77 mmHg, p = 0.002). The suction group also experienced shorter mean operative times (35.98 ± 14.10 min vs. 47.12 ± 15.36 min, p = 0.001) and lithotripsy times (19.50 ± 11.70 min vs. 26.24 ± 10.49 min, p = 0.003). The stone-free rate was higher in the suction group though this difference was not statistically significant. Likewise, the complication rates, including postoperative infection rates (fever and urosepsis) showed a downward trend in the suction group, however the difference was not statistically significant (p > 0.05). Suction mPCNL effectively reduces IRP, shortens operative time, maintains a comparable stone-free rate, making it a safer and more efficient alternative to traditional mPCNL. This study highlights the potential advantages of integrating suction mechanisms to control IRP and improve patient outcomes in PCNL procedures.
- 30 June 2025
- Published by Springer Nature in Urolithiasis
- Vol. 53 (1) , 1-9
Does suction in Mini PCNL mitigate rise in intrarenal pressure? A prospective randomised study
The rise in intra-renal pressure during Mini PCNL (percutaneous nephrolithotripsy) potentially leads to pyelovenous backflow and infectious complications. This prospective randomized study compares intra-renal pressure (IRP) in patients undergoing Mini PCNL (mPCNL) procedure with and without suction for renal stones. Suction mPCNL is expected to lower IRP by continuously aspirating irrigation fluid and stone fragments, thereby enhancing procedural safety. A total of 100 patients with kidney stones measuring 1–4 cm were randomized into two groups: Mini PCNL with suction (n = 50) and Mini PCNL without suction (n = 50). IRP was measured using a pressure transducer connected to a ureteral catheter. Key outcome measures included intra-renal pressure, stone-free rate, operative time, and complication rates. The suction mPCNL group demonstrated a significantly lower IRP (16.92 ± 2.93 mmHg) compared to the non-suction group (19.48 ± 4.77 mmHg, p = 0.002). The suction group also experienced shorter mean operative times (35.98 ± 14.10 min vs. 47.12 ± 15.36 min, p = 0.001) and lithotripsy times (19.50 ± 11.70 min vs. 26.24 ± 10.49 min, p = 0.003). The stone-free rate was higher in the suction group though this difference was not statistically significant. Likewise, the complication rates, including postoperative infection rates (fever and urosepsis) showed a downward trend in the suction group, however the difference was not statistically significant (p > 0.05). Suction mPCNL effectively reduces IRP, shortens operative time, maintains a comparable stone-free rate, making it a safer and more efficient alternative to traditional mPCNL. This study highlights the potential advantages of integrating suction mechanisms to control IRP and improve patient outcomes in PCNL procedures.
- Open Access
- 3 July 2024
- Published by Edorium Journals Pvt. Ltd.
- Vol. 9 (1) , 22-28
Renal artery embolization in a case of renal cell carcinoma with intractable hematuria with acute myocardial infarction
Introduction: Renal artery embolization is a valuable treatment option for various renal tumors, both malignant and benign. The indications for this procedure include preoperative arterial embolization of large and vascular renal cell carcinoma to reduce intraoperative hemorrhagic complications, management of malignant renal tumors in patients who are not suitable candidates for surgery, treatment of symptomatic hematuria and palliative care for metastatic renal cancer. Case Report: In this case report, we present the case of a 56-year-old female with a known history of hypertension and cerebrovascular accident, who presented with complaints of hematuria and urinary retention. A diagnosis of left renal mass suggestive of renal cell carcinoma was made. The patient was planned for left radical nephrectomy and advised to discontinue aspirin for a week. However, on the morning of surgery, she experienced acute myocardial infarction and had to be hospitalized in intensive cardiac care. Aspirin was restarted, leading to recurrent severe hematuria. The patient underwent renal artery embolization, which successfully controlled the hematuria. Following cardiac stabilization, radical nephrectomy was performed three months later. The surgery and post-operative period were uneventful. Conclusion: This case study demonstrates the use of renal artery embolization as an effective modality for controlling hematuria, and temporizing management in a case of renal cell carcinoma where surgery was not immediately feasible due to a medical emergency.
- 3 July 2024
- Published by Edorium Journals Pvt. Ltd.
- Vol. 9 (1) , 22-28
Open AccessRenal artery embolization in a case of renal cell carcinoma with intractable hematuria with acute myocardial infarction
Introduction: Renal artery embolization is a valuable treatment option for various renal tumors, both malignant and benign. The indications for this procedure include preoperative arterial embolization of large and vascular renal cell carcinoma to reduce intraoperative hemorrhagic complications, management of malignant renal tumors in patients who are not suitable candidates for surgery, treatment of symptomatic hematuria and palliative care for metastatic renal cancer. Case Report: In this case report, we present the case of a 56-year-old female with a known history of hypertension and cerebrovascular accident, who presented with complaints of hematuria and urinary retention. A diagnosis of left renal mass suggestive of renal cell carcinoma was made. The patient was planned for left radical nephrectomy and advised to discontinue aspirin for a week. However, on the morning of surgery, she experienced acute myocardial infarction and had to be hospitalized in intensive cardiac care. Aspirin was restarted, leading to recurrent severe hematuria. The patient underwent renal artery embolization, which successfully controlled the hematuria. Following cardiac stabilization, radical nephrectomy was performed three months later. The surgery and post-operative period were uneventful. Conclusion: This case study demonstrates the use of renal artery embolization as an effective modality for controlling hematuria, and temporizing management in a case of renal cell carcinoma where surgery was not immediately feasible due to a medical emergency.